Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials, AAML03P1 and AAML0531.

TitleGemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials, AAML03P1 and AAML0531.
Publication TypeJournal Article
Year of Publication2017
AuthorsGuest EM, Aplenc R, Sung L, Raimondi SC, Hirsch BA, Alonzo TA, Gerbing RB, Wang Y-CJim, Kahwash SB, Heerema-McKenney A, Meshinchi S, Gamis AS
JournalBlood
Date Published2017 Jul 03
ISSN1528-0020
DOI10.1182/blood-2017-01-762336
Alternate JournalBlood
PubMed ID28674028